CelWel

CelWel is a U.S.-based health and wellness company bringing a modern, science-informed approach to chronic inflammatory conditions. Manufactured in Bangalore, India, CelWel’s proprietary sublingual formulation is built around Guduchi (Tinospora cordifolia), a well-known botanical used for centuries in Ayurvedic practice. CelWel is initially focused on people affected by Lyme disease and persistent symptoms associated with complex chronic illness, working primarily through Lyme-literate and integrative medical practitioners. The company has generated early sales through practitioner and direct-to-consumer channels, with more than 150 individual purchases through its website. The company’s approach combines traditional botanical knowledge with contemporary research into immune signaling, inflammation, and neuroinflammatory pathways. Early clinical and real-world evidence includes a 73-patient Lyme disease study and a 15-patient Long COVID study. CelWel is now pursuing a larger double-blind, placebo-controlled study through Radicle Science to further evaluate outcomes and strengthen the evidence base. Beyond Lyme disease, CelWel believes its immune-modulating platform may have relevance across a range of chronic inflammatory conditions, including Long COVID, fibromyalgia, chronic fatigue, and related disorders. The company has also attracted interest for its research exploring potential applications in infectious-disease settings. CelWel’s mission is to make a high-quality, India-manufactured botanical formulation accessible to patients and practitioners in the United States while building the clinical evidence needed to support responsible growth.